Regulation & policy

Menopause claims back under the spotlight following ASA review

Menopause claims back under the spotlight following ASA review

By Olivia Haslam

Women’s health brands Lunera, Minerva Wellness and Nova breached multiple advertising codes by making claims that their supplements could treat or significantly alleviate menopause symptoms, according to the UK’s Advertising Standards Authority (ASA).

Is FDA opening the long‑shut DSHEA ‘innovation door’?

Is FDA opening the long‑shut DSHEA ‘innovation door’?

By Stephen Daniells

The upcoming public Food and Drug Administration (FDA) meeting exploring the scope of dietary supplement ingredients will revisit one of the most contested and, according to DSHEA’s architects, most misunderstood phrases in the U.S. dietary supplement law.

What the 2026 monacolin ban could mean for nutraceutical players

What the 2026 monacolin ban could mean for nutraceutical players

By Olivia Haslam

The European Union is set to ban monacolins from red yeast rice (RYR), a key ingredient in high cholesterol management, as early as Q3 2026, leaving the nutraceutical sector scrambling to fill the resulting ‘therapeutic gap’.

Zoe fails to overturn ASA ruling on gut supplement ad

Zoe fails to overturn ASA ruling on gut supplement ad

By Olivia Haslam

Professor Tim Spector says the Advertising Standards Authority (ASA) decision to uphold its ruling that Zoe’s Daily30+ supplement advertisement was misleading is a profound failure of logic. 

The growing role of toxicology in dietary supplement safety

The growing role of toxicology in dietary supplement safety

By Danielle Masterson

As regulatory enforcement and consumer awareness around dietary supplements continue to grow, manufacturers are under increasing pressure to demonstrate safety. At NOW Foods, that commitment includes employing a dedicated toxicologist, a role that...

New bill aims to end patchwork of state supplement regulations

New bill aims to end patchwork of state supplement regulations

By Cassandra Stern

A Republican congressman has introduced legislation seeking to reaffirm federal oversight of dietary supplements, blocking states from imposing their own additional regulatory requirements and creating what he characterized as a “confusing patchwork of...

Looming folic-acid fortification deadline stirs up UPF debate

Looming folic-acid fortification deadline stirs up UPF debate

By Olivia Haslam

Ingredient distributor ACI Group has called on UK food producers to actively educate consumers about folic acid fortification, warning that misinformation about “ultra-processed foods” is overshadowing the health benefits of the policy.

Longevity ingredients under the EU regulatory spotlight

Longevity ingredients under the EU regulatory spotlight

By Nikki Hancocks

When a health trend takes off, the nimble nutrition industry is adept at creating and marketing new products that fit consumers’ emerging demands. But with this can come a tendency to overlook the regulatory status of burgeoning ingredients. 

Regulatory review: BPOM-HSA collab, China approvals and more

Regulatory review: BPOM-HSA collab, China approvals and more

By Tingmin Koe

The collaboration between the Indonesian Food and Drug Authority (BPOM) and Singapore’s Health Sciences Authority (HSA) on joint assessments of complementary health products and China’s approval of joint health claims are some of the latest updates in...

Supplements 101: Influencer marketing in Europe

Supplements 101: Influencer marketing in Europe

By Lauren Nicolle

As supplement brands lean more heavily on influencers, how can they stay on the right side of regulations, which laws govern creator content, and who is liable for non-compliance?